Related Experiment Video
Updated: Jan 29, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
Yiling Situ1, Liping Chung2,3, Cheok Soon Lee4,5,6,7,8,9
1School of Medicine, Western Sydney University, Penrith, NSW 2751, Australia. ysitu.dr@gmail.com.
Abstract:
The MRE11-RAD50-NBS1 (MRN) complex has been studied in multiple cancers. The identification of MRN complex mutations in mismatch repair (MMR)-defective cancers has sparked interest in its role in colorectal cancer (CRC). To date, there is evidence indicating a relationship of MRN expression with reduced progression-free survival, although the significance of the MRN complex in the clinical setting remains controversial. In this review, we present an overview of the function of the MRN complex, its role in cancer progression, and current evidence in colorectal cancer. The evidence indicates that the MRN complex has potential utilisation as a biomarker and as a putative treatment target to improve outcomes of colorectal cancer.
Insights
The MRE11-RAD50-NBS1 (MRN) complex is implicated in mismatch repair-defective cancers like colorectal cancer (CRC). Research suggests MRN complex alterations may serve as biomarkers and therapeutic targets for improving CRC patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The MRE11-RAD50-NBS1 (MRN) complex is crucial for DNA repair pathways.
- Mutations in the MRN complex are observed in mismatch repair (MMR)-defective cancers.
- Its specific role in colorectal cancer (CRC) warrants further investigation.
Purpose of the Study:
- To review the function of the MRN complex in cancer.
- To explore the MRN complex's role and significance in colorectal cancer progression.
- To assess the potential of the MRN complex as a biomarker and therapeutic target in CRC.
Main Methods:
- Literature review of existing studies on the MRN complex.
- Analysis of evidence linking MRN complex expression to patient survival.
- Synthesis of current research on MRN complex function in CRC.
Main Results:
- Evidence suggests a correlation between MRN complex expression and reduced progression-free survival in some cancers.
- The clinical significance of the MRN complex in colorectal cancer remains debated.
- The MRN complex is implicated in DNA damage response pathways relevant to cancer.
Conclusions:
- The MRN complex plays a role in DNA repair and cancer progression.
- Further research is needed to clarify the controversial clinical significance of the MRN complex in CRC.
- The MRN complex shows potential as a biomarker and therapeutic target for improving colorectal cancer outcomes.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

